Blood test for fungal lung infection in blood cancer patients
Part of Blood & lymphatic, Infections, Lungs & breathing clinical trials.
This trial checks if a blood test can find a fungal lung infection in people with blood cancers or those who had a stem cell transplant. The test looks for fungal DNA in the blood (called mNGS). If it works, it could help doctors diagnose the infection faster and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 14 years or older.
- You have a blood cancer (like leukemia, lymphoma, or myeloma) or you've had a stem cell transplant.
- A chest CT scan shows a spot or spots in your lungs.
- You have symptoms like fever, cough, or trouble breathing that make your doctor think you might have a fungal infection.
- No other infection (like bacteria) has been found from blood or sputum tests.
- You have at least one risk factor: very low white blood cells, long-term steroid use, severe graft-versus-host disease, CMV infection, or T-cell suppressing medicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a sensitive blood test can find hidden fungal infections in people with blood cancers. It may help your doctor start the right treatment sooner.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
This study is testing a new blood or fluid test that may find drug-resistant fungus in people with a weakened immune system who have a serious lung infection. The results could help doctors choose the right medicine faster.
This study uses noninvasive breathing/relates imaging (MRI or CT) to help diagnose mold infections in the lungs in children and young adults. It may help doctors find these infections sooner, especially in people with weakened immune systems.
This trial tests amphotericin B (an antifungal medication) in patients with blood cancers who develop a fungal infection despite already taking antifungal preventive medicine. The study aims to see if this medication can treat these hard-to-treat infections.
This trial tests a blood test that looks for infection by analyzing tiny bits of DNA from microbes. It may help find infections faster in people with weakened immune systems, such as transplant recipients or those with blood cancers.
Hear when a new Invasive Pulmonary Fungal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.